Simpson, G M <br/><br/>
Some methodological considerations in the evaluation of drug-induced extrapyramidal disorders: a study of Ex10-029, a new morphanthridine derivative.  [electronic resource] 

 -  The Journal of clinical pharmacology and new drugs  Apr 1972 
 - 142-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0021-9754 
<br/><br/><label>Standard No.: </label>10.1002/j.1552-4604.1972.tb00043.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiparkinson Agents--therapeutic use<br/>Basal Ganglia Diseases--chemically induced<br/>Biperiden--therapeutic use<br/>Chronic Disease<br/>Clinical Trials as Topic<br/>Cyclohexylamines--therapeutic use<br/>Evaluation Studies as Topic<br/>Handwriting<br/>Humans<br/>Male<br/>Middle Aged<br/>Morphinans--therapeutic use<br/>Movement Disorders--chemically induced<br/>Parkinson Disease--drug therapy<br/>Psychiatric Status Rating Scales<br/>Schizophrenia--complications<br/>Sulfonic Acids--therapeutic use<br/>Time Factors<br/>Tranquilizing Agents--adverse effects